Hoey Timothy

Officer at TNYA; SVP, Cancer Biology & Co-CSO at OncoMed Pharmaceuticals Inc

Sold, on record
$1.3M
Dollars the filings state
Form 4 sales
18
Latest Mar 5, 2024
Form 144 notices
3
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TNYANo plan
    Aug 16 2023

    Sold 4,007 shares at $3.81 ($15k)

    Hoey Timothy, Chief Scientific Officer

    No 10b5-1 planSold 1.5% of holdings ($985k position)254,639 shares leftFiling

  2. 2 Form 144 notice TNYANotice
    Aug 29 +13 days

    Filed to sell 7,243 shares ($31k)

    Hoey Timothy, Officer

    10b5-1 planFiling

  3. 3 Form 4 sale TNYARoutine
    Aug 29 same day

    Sold 7,243 shares at $4.26 ($31k)

    Hoey Timothy, Chief Scientific Officer

    10b5-1 planSold 2.8% of holdings ($1.1M position)247,396 shares leftFollows a Form 144Filing

  4. 4 Form 4 sale TNYANo plan
    Feb 16 +171 days

    Sold 4,681 shares at $5.86 ($27k)

    Hoey Timothy, Chief Scientific Officer

    No 10b5-1 planSold 1.9% of holdings ($1.4M position)242,715 shares left1.2x usual sizeFiling

  5. 5 Form 144 notice TNYANotice
    Feb 20 +4 days

    Filed to sell 6,569 shares ($42k)

    Hoey Timothy, Officer

    10b5-1 plan1.5x usual sizeFiling

  6. 6 Form 4 sale TNYARoutine
    Feb 20 same day

    Sold 6,569 shares at $5.34 ($35k)

    Hoey Timothy, Chief Scientific Officer

    10b5-1 planSold 2.7% of holdings ($1.3M position)236,146 shares left1.5x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice TNYANotice
    Mar 5 +14 days

    Filed to sell 20,000 shares ($132k)

    Hoey Timothy, Officer

    10b5-1 plan4.3x usual sizeFiling

  8. 8 Form 4 sale TNYARoutine
    Mar 5 same day

    Sold 3,300 shares at $7.00 ($23k)

    Hoey Timothy, Chief Scientific Officer

    10b5-1 planSold 1.3% of holdings ($1.7M position)245,346 shares left0.7x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (21)

Form 144 notices and Form 4 sales by Hoey Timothy
Source
Mar 5, 2024TNYAChief Scientific OfficerForm 4 sale3,300$23k1.3%RoutineSEC
Mar 5, 2024TNYAOfficerForm 144 notice20,000$132kNoticeSEC
Feb 20, 2024TNYAChief Scientific OfficerForm 4 sale6,569$35k2.7%RoutineSEC
Feb 20, 2024TNYAOfficerForm 144 notice6,569$42kNoticeSEC
Feb 16, 2024TNYAChief Scientific OfficerForm 4 sale4,681$27k1.9%No planSEC
Aug 29, 2023TNYAChief Scientific OfficerForm 4 sale7,243$31k2.8%RoutineSEC
Aug 29, 2023TNYAOfficerForm 144 notice7,243$31kNoticeSEC
Aug 16, 2023TNYAChief Scientific OfficerForm 4 sale4,007$15k1.5%No planSEC
Apr 26, 2022TNYAChief Scientific OfficerForm 4 sale1,353$14k0.7%Plan not statedSEC
Apr 4, 2017OncoMed Pharmaceuticals IncSVP, Cancer Biology & Co-CSOForm 4 sale5,754$52k9.1%Plan not statedSEC
Jan 3, 2017OncoMed Pharmaceuticals IncSVP, Cancer Biology & Co-CSOForm 4 sale12,763$98k17.3%Plan not statedSEC
Nov 16, 2016OncoMed Pharmaceuticals IncSVP, Cancer Biology & Co-CSOForm 4 sale12,500$124k17.0%Plan not statedSEC
Jan 7, 2016OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale2,162$48k4.4%Plan not statedSEC
Jun 22, 2015OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale5,000$130k9.2%Plan not statedSEC
Apr 27, 2015OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale6,887$177k12.2%Plan not statedSEC
Feb 5, 2015OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale7,500$171k13.1%UnusualSEC
Nov 5, 2014OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale2,500$49k4.8%Plan not statedSEC
Aug 5, 2014OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale2,500$54k4.8%Plan not statedSEC
May 5, 2014OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale2,500$66k4.8%Plan not statedSEC
Mar 5, 2014OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale1,792$64k5.8%Plan not statedSEC
Feb 5, 2014OncoMed Pharmaceuticals IncSVP, Cancer BiologyForm 4 sale5,000$151k14.6%Plan not statedSEC